Published in J Immunol on April 01, 1978
Spatial relationships of microtubule-organizing centers and the contact area of cytotoxic T lymphocytes and target cells. J Cell Biol (1982) 2.26
Resistance of cloned cytotoxic T lymphocytes to cell-mediated cytotoxicity. J Exp Med (1987) 1.58
The mechanism of T-cell mediated cytotoxicity. VI. T-cell projections and their role in target cell killing. Immunology (1979) 1.47
The lysis of cytotoxic T lymphocytes and their blasts by cytotoxic T lymphocytes. Immunology (1990) 0.94
Inhibition of the activity of cytotoxic murine T lymphocytes by antibodies to idiotypic determinants. Immunology (1980) 0.75
Mouse lymphoblasts lose their immunogenicity and susceptibility to specific cytotoxic T lymphocyte lysis during maintenance in culture. Immunology (1998) 0.75
CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma. Nature (1994) 3.70
Spatial relationships of microtubule-organizing centers and the contact area of cytotoxic T lymphocytes and target cells. J Cell Biol (1982) 2.26
Rejection of ascites tumor allografts. I. Isolation, characterization, and in vitro reactivity of peritoneal lymphoid effector cells from BALB-c mice immune to EL4 leukosis. J Exp Med (1972) 2.13
Interaction of cytotoxic T lymphocytes and target cells. Prog Allergy (1980) 2.05
Regression of established murine carcinoma metastases following vaccination with tumour-associated antigen peptides. Nat Med (1995) 1.99
Graft reaction in tissue culture. II. Quantification of the lytic action on mouse fibroblasts by rat lymphocytes sensitized on mouse embryo monolayers. Immunology (1969) 1.93
An antigenic determinant of cytotoxic lymphocytes. Transplantation (1973) 1.65
Cytotoxic T-lymphocytes. How do they function? Immunol Rev (1983) 1.64
Complement resistance of tumor cells: basal and induced mechanisms. Mol Immunol (2000) 1.49
C3 convertase of human complement: enhanced formation and stability of the enzyme generated with nickel instead of magnesium. J Immunol (1982) 1.48
Nature of lymphocyte-tumor interaction. A general method for cellular immunoabsorption. J Exp Med (1973) 1.42
Cytotoxic T lymphocyte hybridomas that mediate specific tumor-cell lysis in vitro. Proc Natl Acad Sci U S A (1981) 1.36
Cytotoxic lymphocytes in the absence of detectable antibody. Nat New Biol (1973) 1.34
Mechanism of lymphocyte-mediated cytolysis. The LMC cycle and its role in transplantation immunity. Transplant Rev (1973) 1.32
T-Lymphocyte-mediated cytolysis as an excitatory process of the target. I. Evidence that the target cell may be the site of Ca2+ action. Cell Immunol (1985) 1.32
Cellular immunoabsorbents in transplantation immunity. Specific in vitro deletion and recovery of mouse lymphoid cells sensitized against allogeneic tumors. J Exp Med (1972) 1.27
Complement resistance of human carcinoma cells depends on membrane regulatory proteins, protein kinases and sialic acid. Clin Exp Immunol (2003) 1.22
Kinetic analysis of a graft reaction induced in cell culture. Immunology (1969) 1.14
T lymphocyte-mediated cytolysis. I. A common mechanism for target recognition in specific and lectin-dependent cytolysis. J Immunol (1981) 1.14
Fas (CD95/Apo-1)-mediated damage to ventricular myocytes induced by cytotoxic T lymphocytes from perforin-deficient mice: a major role for inositol 1,4,5-trisphosphate. Circ Res (1998) 1.13
Tumor immunity in vitro: destruction of a mouse ascites tumor through a cycling pathway. Science (1972) 1.13
T lymphocyte-mediated cytolysis. II. Role of target cell histocompatibility antigens in recognition and lysis. J Immunol (1981) 1.12
Immunolocalization of the Toxin Latrunculin B within the Red Sea Sponge Negombata magnifica (Demospongiae, Latrunculiidae). Mar Biotechnol (NY) (2000) 1.11
Sublytic complement attack protects tumor cells from lytic doses of antibody and complement. Eur J Immunol (1992) 1.09
Graft reaction in tissue culture. 3. Effect of phytohaemagglutinin. Immunology (1969) 1.09
Regulation of the alternative pathway of complement by pH. J Immunol (1987) 1.09
The regulation of CD95 ligand expression and function in CTL. J Immunol (1998) 1.06
Contact regions of cytotoxic T lymphocyte-target cell conjugates. Cell Immunol (1976) 1.06
C3 convertase of the alternative complement pathway. Demonstration of an active, stable C3b, Bb (Ni) complex. J Biol Chem (1983) 1.05
CTLA-1 and CTLA-3 serine esterase transcripts are detected mostly in cytotoxic T cells, but not only and not always. J Immunol (1987) 1.03
Characterization of the initial C3 convertase of the alternative pathway of human complement. J Immunol (1984) 1.03
Functional and antigenic similarities between a 94-kD protein of Schistosoma mansoni (SCIP-1) and human CD59. J Exp Med (1994) 1.01
Rejection of ascites tumor allografts. II. A pathway for cell-mediated tumor destruction in vitro by peritoneal exudate lymphoid cells. J Exp Med (1972) 1.01
Graft reaction in tissue culture by normal rat lymphocytes. Transplant Proc (1969) 0.98
Are lytic granules and perforin 1 involved in lysis induced by in vivo-primed peritoneal exudate cytolytic T lymphocytes? Transplant Proc (1987) 0.96
Proteases secreted by transforming schistosomula of Schistosoma mansoni promote resistance to killing by complement. J Immunol (1988) 0.96
Involvement of the ERK mitogen-activated protein kinase in cell resistance to complement-mediated lysis. Clin Exp Immunol (2001) 0.95
Complement membrane attack complex, perforin, and bacterial exotoxins induce in K562 cells calcium-dependent cross-protection from lysis. J Immunol (1995) 0.95
The lysis of cytotoxic T lymphocytes and their blasts by cytotoxic T lymphocytes. Immunology (1990) 0.94
Inherited complement C3 deficiency: a defect in C3 secretion. Eur J Immunol (1994) 0.93
Monoclonal cytotoxic T lymphocyte hybridomas capable of specific killing activity, antigenic responsiveness, and inducible interleukin secretion. J Immunol (1983) 0.93
Targeting of complement to tumor cells by heteroconjugates composed of antibodies and of the complement component C3b. J Immunol (1989) 0.93
K562 erythroleukemic cells are equipped with multiple mechanisms of resistance to lysis by complement. Int J Cancer (2001) 0.93
Protection of human nasal respiratory epithelium from complement-mediated lysis by cell-membrane regulators of complement activation. Am J Respir Cell Mol Biol (1996) 0.92
Inhibition of lymphocyte-mediated cytolysis by the local anesthetics benzyl and salicyl alcohol. Eur J Immunol (1973) 0.92
Peritoneal exudate lymphocyte and mixed lymphocyte culture hybridomas are cytolytic in the absence of cytotoxic cell proteinases and perforin. Eur J Immunol (1992) 0.92
Evaluation of the effects of cytochalasin B on lymphocyte-mediated cytolysis. Transplantation (1973) 0.91
In vitro induction of a heterograft reaction: immunological parameters of the sensitization of rat lymphocytes against mouse cells in vitro. Transplantation (1971) 0.91
Cell-mediated cytotoxicity results from, but may not be critical for, primary allograft rejection. J Immunol (1996) 0.91
Prevalence of hereditary properdin, C7 and C8 deficiencies in patients with meningococcal infections. Clin Exp Immunol (1990) 0.91
Cell surface glycoproteins of cytotoxic T lymphocytes induced in vivo and in vitro. J Immunol (1981) 0.90
Neutralization of complement regulatory proteins augments lysis of breast carcinoma cells targeted with rhumAb anti-HER2. Immunopharmacology (1999) 0.90
Resistance to NK cell-mediated cytotoxicity (in K-562 cells) does not correlate with class I MHC antigen levels. Immunobiology (1991) 0.90
A rapid method for generating cytotoxic effector cells in vivo. J Immunol Methods (1979) 0.89
The phenomenon of leukergy: induction and detection of leukocyte aggregation in whole human blood. J Lab Clin Med (1987) 0.89
The use of 51Cr release as a measure of lymphocyte-mediated cytolysis in vitro. Cell Immunol (1973) 0.89
The mitogenic activity of staphylococcal enterotoxin B (SEB): a monovalent T cell mitogen that stimulates cytolytic T lymphocytes but cannot mediate their lytic interaction. J Immunol (1986) 0.89
Enumeration of lymphocyte-target cell conjugates by cytofluorometry. Eur J Immunol (1985) 0.88
Selective binding of concanavalin A to target cell major histocompatibility antigens is required to induce nonspecific conjugation and lysis by cytolytic T lymphocytes in lectin-dependent cytotoxicity. Cell Immunol (1984) 0.88
Complement membrane attack complexes induce in human leukemic cells rapid expression of large proteins (L-CIP). Mol Immunol (1992) 0.88
Schistosoma mansoni: evidence for a 28-kDa membrane-anchored protease on schistosomula. Exp Parasitol (1996) 0.88
Clonal expansion of T cells: a cytotoxic T-cell response in vivo that involves precursor cell proliferation. Proc Natl Acad Sci U S A (1986) 0.87
Leishmanial protein kinases phosphorylate components of the complement system. EMBO J (1991) 0.87
Tumor escape from immune elimination. J Theor Biol (1980) 0.87
The role of cytotoxic T lymphocyte projections in target cell lysis. Transplant Proc (1981) 0.87
Macromolecular synthesis during the sensitization of rat lymphcytes on mouse fibroblasts in vitro. Immunochemistry (1971) 0.86
Residual hemolytic and proteolytic activity expressed by Bb after decay-dissociation of C3b,Bb. J Immunol (1984) 0.86
Possible role of nucleus-membrane interaction in capping of surface membrane receptors. Proc Natl Acad Sci U S A (1976) 0.86
Mechanism of blocking by hyperimmune serum of lymphocyte-mediated cytolysis of allogeneic tumor cells. Cancer Res (1973) 0.86
Changes in fluorescence polarization of a membrane probe during lymphocyte-target cell interaction. J Immunol (1978) 0.86
Complement regulation on the surface of cultured schistosomula and adult worms of Schistosoma mansoni. Eur J Immunol (1990) 0.85
Inherited human complement C3 deficiency. An amino acid substitution in the beta-chain (ASP549 to ASN) impairs C3 secretion. J Biol Chem (1994) 0.85
Localization of aggregated cell surface antigens of target cells bound to cytotoxic T lymphocytes. J Exp Med (1975) 0.85
Schistosoma mansoni: isolation and characterization of Smpi56, a novel serine protease inhibitor. Exp Parasitol (1994) 0.84
Cell desensitization by sublytic C5b-9 complexes and calcium ionophores depends on activation of protein kinase C. Eur J Immunol (2000) 0.83
Abnormal glutathione and sulfate levels after interleukin 6 treatment and in tumor-induced cachexia. FASEB J (1996) 0.83
Graft reaction in cell culture. Isr J Med Sci (1969) 0.83
Hereditary properdin deficiency in three families of Tunisian Jews. Acta Paediatr (1993) 0.83
Induction of cell-mediated immunity against leukemia EL4 in C57BL mice. J Natl Cancer Inst (1973) 0.83
Modulation of cell-mediated cytotoxicity function after alteration of fatty acid composition in vitro. J Immunol (1984) 0.83
Shedding of tyrosine and serine/threonine ecto-protein kinases from human leukemic cells. Arch Biochem Biophys (1995) 0.82
Effects of purified perforin and granzyme A from cytotoxic T lymphocytes on guinea pig ventricular myocytes. Cardiovasc Res (1994) 0.82
51 Cr leakage from and uptake of trypan blue by target cells undergoing cell-mediated destruction. Transplantation (1972) 0.82
Receptors for antigen on lymphoid cells. I. Immunoadsorption of plaque-forming cells to poly-L-lysine-fixed antigen monolayers. J Immunol (1974) 0.81
C3 convertase of the human alternative pathway of complement: modulation of enzyme activity and stability by mouse monoclonal antibodies to Bb. Eur J Immunol (1987) 0.81
Schistosoma mansoni: killing of transformed schistosomula by the alternative pathway of human complement. Exp Parasitol (1986) 0.81
Tumor immunity in perforin-deficient mice: a role for CD95 (Fas/APO-1). J Immunol (2000) 0.81
Prelytic reduction of high-energy phosphates induced by antibody and complement in nucleated cells. 31P-NMR study. Complement (1984) 0.81
Phosphorylation of the complement component, C9, by an ecto-protein kinase of human leukemic cells. Immunopharmacology (1999) 0.81
Schistosoma japonicum reveals distinct reactivity with antisera directed to proteases mediating host infection and invasion by cercariae of S. mansoni or S. haematobium. Parasite Immunol (2005) 0.81
T-lymphocyte-mediated cytolysis: contribution of intracellular components to target cell susceptibility. Transplant Proc (1977) 0.80
Activity of tumor-associated lymphoid cells at short intervals after administration of irradiated syngeneic and allogeneic tumor cells. J Immunol (1977) 0.80
Fluorescence polarization as an early measure of T-lymphocyte stimulation. Methods Mol Biol (2000) 0.79
An appraisal of some current thoughts on cytolytic T-lymphocyte killing mechanisms. Ann Inst Pasteur Immunol (1987) 0.79
Enhanced sensitivity of P-glycoprotein-positive multidrug resistant tumor cells to complement-mediated lysis. Eur J Immunol (1997) 0.79
Enhanced complement resistance in drug-selected P-glycoprotein expressing multi-drug-resistant ovarian carcinoma cells. Clin Exp Immunol (2008) 0.79
The pathway of lectin-mediated lymphocytotoxicity by Con A-coupled Sepharose beads. Cell Immunol (1984) 0.79